Total global 2013 sales totaled $28.5 million, up from 2012’s $27.4 million. Fourth quarter device sales, which totaled $7.3 million, dropped 1 percent compared to the same period last year.
Year-end orthopedic device sales reached $9.5 million, up nearly 22 percent from 2012’s $7.7 million in sales.
The company’s net income for 2013 was $13.8 billion, up from $10.5 billion in 2012.
More Articles on Devices:
Titan Spine Gains 5 Patents for Endoskeleton Interbody Devices
Budgetary Fund Could Pay to Eliminate Medical Device Tax
Intellirod Spine Secures $1.6M Loan From Ohio Third Frontier
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
